KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Equity Ratio (2018 - 2025)

Historic Equity Ratio for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to 0.71.

  • Twist Bioscience's Equity Ratio fell 459.18% to 0.71 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.71, marking a year-over-year decrease of 459.18%. This contributed to the annual value of 0.74 for FY2025, which is 423.59% down from last year.
  • Twist Bioscience's Equity Ratio amounted to 0.71 in Q4 2025, which was down 459.18% from 0.74 recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Equity Ratio peaked at 0.91 during Q1 2021, and registered a low of 0.71 during Q4 2025.
  • In the last 5 years, Twist Bioscience's Equity Ratio had a median value of 0.8 in 2023 and averaged 0.8.
  • Over the last 5 years, Twist Bioscience's Equity Ratio had its largest YoY gain of 1116.28% in 2021, and its largest YoY loss of 1265.74% in 2021.
  • Twist Bioscience's Equity Ratio (Quarter) stood at 0.8 in 2021, then grew by 2.97% to 0.82 in 2022, then fell by 1.83% to 0.81 in 2023, then fell by 6.95% to 0.75 in 2024, then dropped by 4.59% to 0.71 in 2025.
  • Its last three reported values are 0.71 in Q4 2025, 0.74 for Q3 2025, and 0.74 during Q2 2025.